New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays
Open accessThe DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index; 9 of the 54 sources its claims cite were checked for support.
Abstract
Context: The normal cortisol response 30 or 60 minutes after cosyntropin (ACTH[1–24]) is considered to be ≥18 μg/dL (500 nmol/L). This threshold is based on older serum cortisol assays. Specific monoclonal antibody immunoassays or LC-MS/MS may have lower thresholds for a normal response. Objective: To calculate serum cortisol cutoff values for adrenocorticotropic hormone (ACTH) stimulation testing with newer specific cortisol assays. Methods: Retrospective analysis of ACTH stimulation tests performed in ambulatory and hospitalized patients suspected of adrenal insufficiency (AI). Serum samples were assayed for cortisol in parallel using Elecsys I and Elecsys II immunoassays, and when volume was available, by Access immunoassay and LC-MS/MS. Results: A total of 110 patients were evaluated. Using 18 μg/dL as the cortisol cutoff after ACTH stimulation, 14.5%, 29%, 22.4%, and 32% of patients had a biochemical diagnosis of AI using the Elecsys I, Elecsys II, Access, and LC-MS/MS assays, respectively. Deming regressions of serum cortisol were used to calculate new cortisol cutoffs based on the Elecsys I cutoff of 18 μg/dL. For 30-minute values, new cutoffs were 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS. Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values. Conclusion: To reduce false positive ACTH stimulation testing, we recommend a new serum cortisol cutoff of 14 to 15 μg/dL depending on the assay used (instead of the historical value of 18 μg/dL with older polyclonal antibody assays). Clinicians should be aware of the new cutoffs for the assays available to them when evaluating patients for AI.
Overview
CoChat Summary
TL;DR
In 110 patients suspected of adrenal insufficiency, newer specific cortisol assays gave lower ACTH-stimulated cortisol values than the older Elecsys I polyclonal assay, so the historical 18 μg/dL cutoff produced more biochemical AI diagnoses. The authors recommend assay-specific post-cosyntropin cutoffs of 14 to 15 μg/dL to reduce false-positive ACTH stimulation tests.
Key findings
- Using the historical 18 μg/dL cutoff, biochemical AI was diagnosed in 14.5% with Elecsys I, 29% with Elecsys II, 22.4% with Access, and 32% with LC-MS/MS.
- Deming regression from the Elecsys I 18 μg/dL cutoff yielded 30-minute cutoffs of 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS; 60-minute cutoffs were 14.7, 14.5, and 13.7 μg/dL, respectively.
- Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values, while values between 2 and 8 μg/dL overlapped substantially between normal and subnormal responders.
- Discordant CST results occurred in 8 of 110 patients (7.3%) across assays using new cutoffs; most abnormal values were close to the cutoff, and clinical review identified secondary AI in 3 of these 8.
Methods
- Retrospective analysis of residual serum samples from 110 ambulatory and hospitalized patients undergoing cosyntropin stimulation testing for suspected adrenal insufficiency from January 8, 2017 to April 30, 2017.
- Cosyntropin (250 mcg ACTH[1–24]) was given intravenously, with serum cortisol measured before injection and at 30 minutes; 60-minute samples were analyzed when ordered. Samples were run in parallel on Elecsys I and Elecsys II, and when volume allowed, on Beckman Access and LC-MS/MS.
- Deming regression was used to calculate new cutoffs from Elecsys I, with Bland-Altman bias analysis, ROC analysis, repeated-measures ANOVA, Mann-Whitney, and chi-square tests.
Limitations
- The paper states there was no independent endocrine test to determine whether patients truly had AI, and many patients lacked long-term follow-up to confirm chronic AI or sustained glucocorticoid need.
- The paper states the cohort came from diverse clinical settings and did not include a healthy subject cohort, though prior healthy-subject studies using specific assays found similar lower thresholds.
- The paper notes CST interpretation is limited without pre-test probability and may be affected by serum protein levels, concurrent medications, and proper timely execution; evident from the text, this was a retrospective single-protocol study using residual samples, with some assays having smaller sample numbers because of insufficient serum volume.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
5 Valid · 3 Not valid · 16 Not checked · 62 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Newer, more-specific cortisol assays with lower cross-reactivity to other endogenous steroids have replaced older, less-specific assays [8, 13, 15, 26, 27].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Not checked — no full text of the sourcecites [8] Kline, 2017, Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay, Clin Biochem. source
- Not checked — no full text of the sourcecites [13] Raverot, 2016, Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay, Ann Endocrinol (Paris). source
- Disputedcites [15] Vogeser, 2017, Multicenter performance evaluation of a second generation cortisol assay, Clin Chem Lab Med. sourceExperimental — accuracy not yet measured
The Introduction (p. 2) says the second-generation assay was developed to improve specificity. But Table 2 (p. 4) reports greater cross-reactivity with cortisone, an endogenous steroid, for Cortisol II than for the first-generation assay (6.58% versus 0.30%). The paper also describes development and comparison of the two assays, not a general replacement of older assays. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [26] Ueland, 2018, The short cosyntropin test revisited: new normal reference range using LC-MS/MS, J Clin Endocrinol Metab. source
- Not checked — no full text of the sourcecites [27] El-Farhan, 2013, Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays, Clin Endocrinol (Oxf). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Serum cortisol concentrations are approximately 20% lower with the newer assays compared with the older assays in some studies [8, 13, 15, 26, 27].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Abstract > Conclusion
What the sources say
- Not checked — no full text of the sourcecites [8] Kline, 2017, Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay, Clin Biochem. source
- Not checked — no full text of the sourcecites [13] Raverot, 2016, Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay, Ann Endocrinol (Paris). source
- Supportedcites [15] Vogeser, 2017, Multicenter performance evaluation of a second generation cortisol assay, Clin Chem Lab Med. source
The Method comparisons section (p. 5) reports that, for 541 serum samples, the second-generation Cortisol II assay had a slope of 0.76 and an intercept of 10.3 nmol/L relative to the first-generation assay. Those results support approximately 20% lower readings with the newer assay, though the percentage difference varies with concentration. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] Ueland, 2018, The short cosyntropin test revisited: new normal reference range using LC-MS/MS, J Clin Endocrinol Metab. source
- Not checked — no full text of the sourcecites [27] El-Farhan, 2013, Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays, Clin Endocrinol (Oxf). source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Grassi et al also found lower cortisol cutoff values of 12.7 and 13.3 μg/dL using Elecsys II and LC-MS/MS assays, respectively [37].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Supportedcites [37] Grassi, 2020, Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience, Hormones (Athens). source
The Discussion reports that the 500 nmol/L threshold corresponded to 351 nmol/L (12.7 μg/dL) with R2 and 368 nmol/L (13.3 μg/dL) with LC-MS/MS. The Assays section identifies R2 as Elecsys Cortisol II, matching the assays and values in the claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Not checked — no full text of the sourcecites [26] Ueland, 2018, The short cosyntropin test revisited: new normal reference range using LC-MS/MS, J Clin Endocrinol Metab. source
- Not checked — no full text of the sourcecites [28] Burt, 2013, Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH1–24 stimulation in the assessment of pituitary patients, J Clin Endocrinol Metab. source
- Could not verifycites [38] Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome, N Engl J Med. sourceExperimental — accuracy not yet measured
The Methods section on study patients describes biochemical criteria for corticotropin-independent Cushing’s syndrome, not an ACTH stimulation test comparing cortisol at 30 and 60 minutes. Searches for the quoted comparison and for ACTH stimulation with 30- and 60-minute cortisol assays found no passage addressing it in our copy. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On chart review, 3 of these 8 patients were clinically thought to have secondary AI.”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Results
plainn = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The proposed cutoffs may be applicable to other LC-MS/MS methods after validation but may differ for immunoassays (43, 44).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“The current diagnostic strategy for adrenal insufficiency is for patients to be referred for an ACTH stimulation test, using a cutoff to confirm (<15.6 mg/dl [430 nmol/l]) or exclude (15.6 mg/dl [430 nmol/l]) adrenal insufficiency.”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [26]
In the citing paper
“In the current study, adrenal insufficiency was defined as a peak cortisol level of <15.6 mg/dl (<430 nmol/l) measured by immunoassay.”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [26]
In the citing paper
“The new tools available to detect cortisol are the immunoassays utilizing monoclonal antibodies, such as Elecsys Cortisol generation II and Beckman Access Cortisol, and the Liquid chromatography–tandem mass spectrometry (LC-MS/MS), which is a non-antibody structural assay highly specific for cortisol [41,42,43,44].”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [44]
In the citing paper
“Over the last years, newer-generation assays with greater specificity for cortisol have been developed and have replaced the old assays in almost all the centers.”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [44]
Citations
Cites
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · cited 3×
“Patients with primary AI always have an elevated plasma ACTH, so CST is typically not needed for confirmation of the diagnosis [5, 6].”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737 · cited 2×
“As with any endocrine test, no absolute cortisol cutoff for the ACTH stimulation test is perfect for the diagnosis of AI [4, 7, 11, 12].”
BackgroundCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310359 · Cited by 443 · cited 1×
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442 · cited 6×
“Historically, immunoassays using polyclonal antibodies have been used to establish post-cosyntropin cortisol cutoff concentrations as high as 20 μg/dL [11, 12].”
BackgroundMethodInfluentialHusebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · cited 1×
“Patients with primary AI always have an elevated plasma ACTH, so CST is typically not needed for confirmation of the diagnosis [5, 6].”
BackgroundValue of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233 · cited 2×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodRapid adrenocorticotropic hormone test in practice. Retrospective review
May, M. E., & Carey, R. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90517-0 · Cited by 174 · cited 3×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodThe approach to the adult with newly diagnosed adrenal insufficiency
Arlt, W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0032 · Cited by 165 · cited 1×
“Historically, a cortisol level at 30 or 60 minutes of >18 μg/ dL has been considered normal [5, 9, 10, 35, 36].”
BackgroundEl‐Farhan, N., Pickett, A., Ducroq, D., Bailey, C., Mitchem, K., Morgan, N., Armston, A., Jones, L., Evans, C., & Rees, D. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12039 · Cited by 158 · cited 2×
“Serum cortisol concentrations are approximately 20% lower with the newer assays compared with the older assays in some studies [8, 13, 15, 26, 27].”
BackgroundMethodSchmidt, I. L., Lahner, H., Mann, K., & Petersenn, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021897 · Cited by 149 · cited 2×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodLC–MS/MS analysis of steroids in the clinical laboratory
Keevil, B. G. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.009 · Cited by 149 · cited 1×
“Liquid chromatography–tandem mass spectrometry (LC-MS/MS) is a non-antibody, structural assay highly specific for cortisol [22-25].”
Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease
Mayenknecht, J., Diederich, S., Bähr, V., Plöckinger, U., & Oelkers, W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4831 · Cited by 142 · cited 1×
“This is not surprising since the high dose and low dose cosyntropin generate plasma ACTH concentrations of 22 000 to 100 000 pg/mL and 2000 pg/mL, respectively, at 2 minutes after injection [33, 34].”
BackgroundAdrenal insufficiency: etiology, diagnosis and treatment
Neary, N., & Nieman, L. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328338f608 · Cited by 140 · cited 1×
“Historically, a cortisol level at 30 or 60 minutes of >18 μg/ dL has been considered normal [5, 9, 10, 35, 36].”
BackgroundKlose, M., Lange, M., Rasmussen, A. K., Skakkebæk, N. E., Hilsted, L., Haug, E., Andersen, M., & Feldt-Rasmussen, U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1791 · Cited by 140 · cited 5×
“Historically, a cortisol level at 30 or 60 minutes of >18 μg/ dL has been considered normal [5, 9, 10, 35, 36].”
BackgroundMethodResultInfluentialMazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96
Serum cortisol: an up-to-date assessment of routine assay performance
Hawley, J. M., Owen, L. J., Lockhart, S. J., Monaghan, P. J., Armston, A., Chadwick, C. A., Wilshaw, H., Freire, M., Perry, L., & Keevil, B. G. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255034 · Cited by 95 · cited 1×
“Liquid chromatography–tandem mass spectrometry (LC-MS/MS) is a non-antibody, structural assay highly specific for cortisol [22-25].”
The short cosyntropin test revisited: new normal reference range using LC-MS/MS
Ueland, G. Å., Methlie, P., Øksnes, M., Thordarson, H. B., Sagen, J., Kellmann, R., Mellgren, G., Ræder, M., Dahlqvist, P., Dahl, S. R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02602 · Cited by 71 · cited 4×
“Despite that, previous studies in healthy subjects using more-specific cortisol assays including LC-MS/MS have found a lower peak cortisol response to ACTH stimulation that was very similar to the lower cortisol threshold reported in our study [10, 26].”
BackgroundMethodResultInfluentialFindling, J. W., Buggy, B. P., Gilson, I. H., Brummitt, C. F., Bernstein, B. M., & Raff, H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962279 · Cited by 69 · cited 2×
“The CST cortisol cutoff threshold for the diagnosis of AI 30 or 60 minutes after ACTH administration has evolved over the years, but it has become entrenched at 18 μg/dL (500 nmol/L) despite improved specificity of newer cortisol assays [5, 8-10].”
BackgroundSelf-citationRaverot, V., Richet, C., Morel, Y., Raverot, G., & Borson-Chazot, F. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.05.002 · Cited by 66 · cited 5×
“Regardless, the cortisol response to insulininduced hypoglycemia would be lower than 18 μg/dL with specific cortisol assays [13].”
BackgroundMethodInfluentialMulticenter performance evaluation of a second generation cortisol assay
Vogeser, M., Kratzsch, J., Ju Bae, Y., Bruegel, M., Ceglarek, U., Fiers, T., Gaudl, A., Kurka, H., Milczynski, C., Prat Knoll, C., et al. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0400 · Cited by 65 · cited 4×
“Newer-generation assays with greater specificity for cortisol have been developed and have already replaced polyclonal antibody assays in many institutions [13, 15, 16].”
BackgroundMethodInfluentialKline, G., Buse, J., & Krause, R. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.02.008 · Cited by 62 · cited 3×
“Serum cortisol concentrations are approximately 20% lower with the newer assays compared with the older assays in some studies [8, 13, 15, 26, 27].”
BackgroundMethodKaraca, Z., Tanriverdi, F., Atmaca, H., Gokce, C., Elbuken, G., Selcuklu, A., Unluhizarci, K., & Kelestimur, F. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0229 · Cited by 52 · cited 2×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodGreene, L. W., Geer, E. B., Page-Wilson, G., Findling, J. W., & Raff, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00027 · Cited by 49 · cited 1×
“Plasma ACTH was measured using the Roche Cobas platform immunometric assay [31, 32].”
MethodSelf-citationGrassi, G., Morelli, V., Ceriotti, F., Polledri, E., Fustinoni, S., D’Agostino, S., Mantovani, G., Chiodini, I., & Arosio, M. (2020) · Hormones · doi:10.1007/s42000-020-00185-y · Cited by 46 · cited 1×
“3 μg/dL using Elecsys II and LC-MS/MS assays, respectively [37].”
MethodCase for the wider adoption of mass spectrometry-based adrenal steroid testing, and beyond
Monaghan, P. J., Keevil, B. G., Stewart, P. M., & Trainer, P. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2258 · Cited by 41 · cited 1×
“Liquid chromatography–tandem mass spectrometry (LC-MS/MS) is a non-antibody, structural assay highly specific for cortisol [22-25].”
Diagnostic performance of basal cortisol level at 0900-1300h in adrenal insufficiency
Manosroi, W., Phimphilai, M., Khorana, J., & Atthakomol, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225255 · Cited by 41 · cited 1×
“Varying cutoffs for basal cortisol levels have been suggested to predict AI [11, 17-19, 41].”
BackgroundBurt, M. G., Mangelsdorf, B. L., Rogers, A., Ho, J. T., Lewis, J. G., Inder, W. J., & Doogue, M. P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3576 · Cited by 30 · cited 2×
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
ResultEstimation of maximal cortisol secretion rate in healthy humans
Dorin, R. I., Qiao, Z., Qualls, C. R., & Urban, F. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2227 · Cited by 29 · cited 5×
“As with any endocrine test, no absolute cortisol cutoff for the ACTH stimulation test is perfect for the diagnosis of AI [4, 7, 11, 12].”
BackgroundInfluentialThe use of mass spectrometry to improve the diagnosis and the management of the HPA axis
Monaghan, P. J., Keevil, B. G., & Trainer, P. J. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9240-1 · Cited by 28 · cited 1×
“Liquid chromatography–tandem mass spectrometry (LC-MS/MS) is a non-antibody, structural assay highly specific for cortisol [22-25].”
RAFF, H., FINDLING, J. W., & WONG, J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-678 · Cited by 26 · cited 1×
“This is not surprising since the high dose and low dose cosyntropin generate plasma ACTH concentrations of 22 000 to 100 000 pg/mL and 2000 pg/mL, respectively, at 2 minutes after injection [33, 34].”
BackgroundSelf-citationMunro, V., Elnenaei, M., Doucette, S., Clarke, D. B., & Imran, S. A. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.02.010 · Cited by 20 · cited 1×
“These data would support the notion that 30-minute cortisol values after high dose CST provide more sensitivity, but less specificity than 60-minute cortisol values [39].”
BackgroundHuayllas, M. K. P., Netzel, B. C., Singh, R. J., & Kater, C. E. (2018) · Laboratory Medicine · doi:10.1093/labmed/lmy005 · Cited by 19 · cited 1×
“The serum LC-MS/MS assay method has been described previously [30].”
MethodSelf-citationKalaria, T., Buch, H., Agarwal, M., Chaudhari, R., Gherman‐Ciolac, C., Chopra, R., Okeke, V., Kaur, S., Hughes, L., Sharrod‐Cole, H., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14388 · Cited by 14 · cited 2×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
MethodJonklaas, J., Holst, J. P., Verbalis, J. G., Pehlivanova, M., & Soldin, S. J. (2012) · Endocrine Practice · doi:10.4158/ep11085.or · Cited by 8 · cited 1×
“However, other studies have actually suggested that LC-MS/MS yielded a higher peak cortisol cutoff after ACTH stimulation than cortisol measured by immunoassay [28, 29].”
ResultDiagnosis and Management of Adrenal Insufficiency
He, X., Findling, J. W., & Auchus, R. J. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_9 · Cited by 6
Self-citation
Cited by
Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 141
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 88
“…assays a basal morning serum cortisol of about 10.5 µg/dl (300 nmol/l) indicates an intact axis 192 , and cortrosyn-stimulated values of 13.2–15.7 µg/dl (364–433 nmol/l) at 30 min or 14.6–17.9 µg/dl (403–494 nmol/l) at 60 min suggest that glucocorticoid replacement can be discontinued 192–195 .”
InfluentialHome waking salivary cortisone to screen for adrenal insufficiency
Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200182 · Cited by 66
Kumar, R., & Wassif, W. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207895 · Cited by 69
Cortisol: Biosensing and detection strategies
Balasamy, S., Atchudan, R., Arya, S. K., Gunasekaran, B. M., Nesakumar, N., & Sundramoorthy, A. K. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119888 · Cited by 53
Metadata
- Authors
- Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W.
- Affiliations
- Froedtert Hospital (US)
- Medical College of Wisconsin (US)
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
- Mayo Clinic (US)
- Corresponding author
- Javorsky, Bradley R
- ORCID
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2021-02-18
- Volume
- 5
- Issue
- 4
- Pages
- bvab022-bvab022
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC7975762
- OpenAlex
- W3132722879
- Semantic Scholar
- d204c31770bedad774ffe4ea48c1fe1f03f7bedd
- Cited by
- 171
- References
- 39
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 37 · 2023: 32 · 2022: 24 · 2021: 11
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Advocate Aurora Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- adrenal insufficiency, ACTH stimulation test, monoclonal antibody assay, false positives, baseline cortisol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.